Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients

Intensive Care Medicine

Volumn 35, Issue 11, 2009, Pages 1859-1867

  Guignant, Caroline ^a   Voirin, Nicolas ^b   Venet, Fabienne ^a   Poitevin, Françoise ^a   Malcus, Christophe ^a   Bohé, Julien ^c   Lepape, Alain ^c   Monneret, Guillaume ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Adrenomedullin; Mortality; Prognosis; Septic shock; Vasopressin

Indexed keywords

ADRENOMEDULLIN; BIOLOGICAL MARKER; COPEPTINS; GLYCOPEPTIDE; PROADRENOMEDULLIN; PROTEIN PRECURSOR;

AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CHEMOLUMINESCENCE; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; IMMUNOASSAY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PREDICTION AND FORECASTING; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SEPTIC SHOCK; STATISTICAL MODEL; VALIDATION STUDY;

ADRENOMEDULLIN; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FRANCE; GLYCOPEPTIDES; HUMANS; IMMUNOASSAY; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC;

EID: 73949142623     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-009-1610-5     Document Type: Article

References (32)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 9:1303-1310
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1244-1250
3. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63-78
4. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J M 348:138-150
5. Carlet J, Cohen J, Calandra T, Opal SM, Masur H (2008) Sepsis: time to reconsider the concept. Crit Care Med 36:964-966
6. Marshall JC (2008) Sepsis: rethinking the approach to clinical research. J Leukoc Biol 83:471-482
7. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S (2004) Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32:1928-1948
8. Flierl MA, Rittirsch D, Huber-Lang MS, Sarma JV, Ward PA (2008) Molecular events in the cardiomyopathy of sepsis. Mol Med 14:327-336
9. Matsuda N, Hattori Y (2007) Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 43:117-137
10. Treschan TA, Peters J (2006) The vasopressin system: physiology and clinical strategies. Anesthesiology 105:599-612
11. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D (2003) Circulating vasopressin levels in septic shock. Crit Care Med 31:1752-1758
12. Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138-167
13. Zudaire E, Portal-Núñez S, Cuttitta F (2006) The central role of adrenomedullin in host defense. J Leukoc Biol 80:237-244
14. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M (2007) Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28:219-226
15. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B (2005) Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9:R816-R824
16. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ (2008) Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 12:R11
17. Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B (2006) Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care 10:R96
18. Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F (2007) Midregional pro-A-type natriuretic peptide and carboxyterminal provasopressin may predict prognosis in community-acquired pneumonia. Clin Chem 53:2193-2201
19. Müller B, Morgenthaler N, Stolz D, Schuetz P, Müller C, Bingisser R, Bergmann A, Tamm M, Christ-Crain M (2007) Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 37:145-152
20. Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T, CAPNETZ Study Group (2007) CAPNETZ Study Group: pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33:2069-2078
21. Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455
22. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32:1175-1183
23. McCabe WR, Jackson GC (1962) Gram-negative bacteremia. Arch Intern Med 110:847-864
24. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
25. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26:1793-1800
26. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2005) Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823-1829
27. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119
28. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B (2007) Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 14:345-351
29. Khan SQ, Dhillon O, Struck J, Quinn P, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester acute myocardial infarction peptide (LAMP) study. Am Heart J 154:736-742
30. Khan SQ, O'Brien RJ, Struck J, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester acute myocardial infarction peptide) study. J Am Coll Cardiol 49:1525-1532
31. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester acute myocardial infarction peptide (LAMP) study. Circulation 115:2103-2110
32. de Kruif MD, Lemaire LC, Giebelen IA, Struck J, Morgenthaler NG, Papassotiriou J, Elliott PJ, van der Poll T (2008) The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 34:518-522